Outpatient Anticoagulation Treatment Packet



Similar documents
Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Outpatient Treatment of Deep Vein Thrombosis with Low Molecular Weight Heparin (LMWH) Clinical Practice Guideline August 2013

PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults

Enoxaparin for long term anticoagulation in patients unsuitable for oral anticoagulants

Updates to the Alberta Drug Benefit List. Effective January 1, 2016

Updates to the Alberta Human Services Drug Benefit Supplement

Anticoagulation Dosing at UCDMC Indication Agent Standard Dose Comments and Dose Adjustments VTE Prophylaxis All Services UFH 5,000 units SC q 8 h

Traditional anticoagulants

Anticoagulant therapy

Objectives. Patient Background. Transitioning a Patient To & From a New Oral Anticoagulant

New Oral Anticoagulants. How safe are they outside the trials?

What Does Pregnancy Have to Do With Blood Clots in a Woman s Legs?

Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)

DVT/PE Management with Rivaroxaban (Xarelto)

Dorset Cardiac Centre

A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT

NHS FORTH VALLEY RIVAROXABAN AS TREATMENT FOR DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN ADULTS

ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Preventing Blood Clots After Hip or Knee Replacement Surgery or Surgery for a Broken Hip. A Review of the Research for Adults

9/28/15. Dabigatran. Rivaroxaban. Apixaban. Edoxaban. From the AC Forum Centers of Excellence website: Dabigatran, Rivaroxaban, & Apixaban

Common Drug Review Pharmacoeconomic Review Report

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

ORAL ANTICOAGULANTS RIVAROXABAN (XARELTO) FOR PULMONARY EMBOLISM (PE)

MEDICAL ASSISTANCE BULLETIN

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

What You Need to KnowWhen Taking Anticoagulation Medicine

Program Objectives. Why Use Anticoagulants? 6/5/2014

TSOAC Initiation Checklist

Sudden dizziness, trouble walking, loss of balance or coordination

Anticoagulation Therapy Update

Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12

Low Molecular Weight Heparin. All Wales Medicines Strategy Group (AWMSG) Recommendations and advice

FDA Approved Oral Anticoagulants

Advanced Issues in Peri-Operative VTE Prevention

Introduction. Background to this event. Raising awareness 09/11/2015

To provide an evidenced-based approach to treatment of patients presenting with deep vein thrombosis.

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

Use of Antithrombotic Agents In The Presence Of Neuraxial Anesthesia

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Clinical Study Synopsis

Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008:

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Anticoagulants in Atrial Fibrillation

Oxford Anticoagulation & Thrombosis Service Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Thrombosis and Hemostasis

MCHENRY WESTERN LAKE COUNTY EMS SYSTEM OPTIONAL CE ADVANCED LEVEL (EMTP, PHRN, ECRN) August Anticoagulants

Venous Thromboembolic Treatment Guidelines

Update on Antiplatelets and anticoagulants. Outlines. Antiplatelets and Anticoagulants 1/23/2013. Timir Paul, MD, PhD

New Oral Anticoagulants

RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home

COMPARISON OF NEW ORAL ANTICOAGULANTS AND FREQUENTLY- ASKED QUESTIONS FROM PATIENTS. TARGET AUDIENCE: All Canadian health care professionals.

2.5mg SC daily. INR target mg SC q 12 hr or 40mg daily. 10 mg PO q day (CrCl 30 ml/min). Avoid if < 30 ml/min. 2.

Venous Thromboembolism: Long Term Anticoagulation. Dan Johnson, Pharm.D.

CDEC RECORD OF ADVICE

NOAC Reversal Agent Think Tank Follow-Up: Post Approval Safety & Effectiveness Pharmacoepidemiologic Approaches and Big Data

How To Take Xarelto

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

Newer Anticoagulants and Newer Diabetic Drug Classes. Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013

Anticoagulation Essentials! Parenteral and Oral!

These are just some of the eligibility requirements meeting these criteria does not guarantee acceptance.

A PRACTICAL REVIEW OF THE NOVEL ORAL ANTICOAGULANTS

Novel Oral Anticoagulants (NOACs) Prescriber Update 2013

A PATIENT S GUIDE TO PULMONARY EMBOLISM TREATMENT

Prostate Assessment Pathway Prostate Biopsy Alerts

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

PRESCRIBING GUIDELINES FOR THE MANAGEMENT OF PATIENTS ANTICOAGULANT THERAPY

Use of Novel Oral Anticoagulants (NOACs) and the new DAWN modules at Scripps

0.9% Sodium Chloride injection may be used in most cases.

Anticoagulation at the end of life. Rhona Maclean

Title Use of rivaroxaban in suspected DVT in the Emergency Department Standard Operating Procedure. Author s job title. Pharmacist.

Overview of the TJC/CMS VTE Core Measures

Anticoagulants. Anticoagulants Definition. When are blood clots GOOD? Where and why do blood clots occur? 6/12/2014

Safety Information Card for Xarelto Patients

Critical Bleeding Reversal Protocol

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

Appendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages

Treatment with Rivaroxaban

STARTING, SWITCHING OR STOPPING NEW ORAL ANTICOAGULANTS: A Practical Approach

NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation

Sara Weelborg, ARNP 6625 Wagner Way NW, Suite 350 Psychiatric Nurse Practitioner Gig Harbor, WA (360) My Policies and Philosophy

Patient Group Direction Hospital: Bristol Royal Infirmary Department: UHBristol Thrombosis Service University Hospitals Bristol NHS Foundation Trust.

The author has no disclosures

Community Center Readiness Guide Additional Resource #17 Protocol for Physician Assistants and Advanced Practice Nurses

(928) MEDICAL HISTORY. Weight: _ Shoe size: _

News Release. Media Contacts: Kristina Chang Tel: (908) Mobile: (201)

CDEC FINAL RECOMMENDATION

Committee Approval Date: September 12, 2014 Next Review Date: September 2015

Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude..

STROKE PREVENTION IN ATRIAL FIBRILLATION

Session 3 Topics. Argatroban. Argatroban. Drug Use and Adverse Effects. Laboratory Monitoring of Anticoagulant Therapy

Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

2. Background This indication of rivaroxaban had not previously been considered by the PBAC.

Warfarin and Novel Anti-Coagulants: Management Before and After the Cath Lab

Welcome to North Texas Orthopaedic & Spine 955 Garden Park Dr. Ste. 200 Allen Texas Today s Date: How did you hear of our practice?

Transcription:

Emergency / Pharmacy Services Outpatient Anticoagulation Treatment Packet Check when complete (If indicated): Primary Care Provider Follow Referral to Franciscan Transitional Clinic (if no primary care provider - information provided on primary care provider referral services) Outpatient DVT Treatment Physician Order Anticoagulation Clinic Referral Complete EPIC Order ref111f (to be electronically signed by ED medical provider) Outpatient Anticoagulation Discharge Agreement Letter Outpatient Anticoagulation Treatment Program: Enrollment and Discharge Instructions (Select appropriate document based on treatment option scheduled) Enoxaparin and Warfarin prescriptions (ED medical provider to complete and sign) if option #1 selected Rivaroxaban (or alternative Xa inhibitor, based on insurance coverage) prescriptions (ED medical Provider to complete and sign) if option #2 selected Vouchers / Medication Assistance Algorithm complete (medication specific programs available) Patient education Enoxaparin Discharge Kit (if necessary) Patient education Warfarin material (if necessary) Patient education Rivaroxaban Discharge Kit (if necessary) Education provided and documented in patient chart on Enoxaparin, Warfarin, or Rivaroxaban (or alternative Xa inhibitor) and follow-up arranged Please sign when complete Pharmacist Name: :

Outpatient DVT Treatment [30400736] NOTE: IF PATIENT MEETS CRITERIA, CHOOSE 1 DVT TREATMENT REGIMEN, NOT BOTH Exclusion criteria: Less than 18 years old Weight less than 35 kg Pregnant Active, known bleeding or excessive risk (PUD, GI, severe liver disease, thrombocytopenia) CVA, CNS/cord injury, or Major Surgery less than 10 days Renal Failure (serum creatinine greater than 3) Significant Cardiopulmonary disease Known Substance or Alcohol Abuse Labs Baseline Labs [128012] Hemoglobin [LAB291] Hematocrit [LAB289] Platelet Count [LAB301] Protime-INR [LAB320] Hepatic Function Panel [LAB20] Creatinine, Serum [LAB66] Outpatient Treatment Outpatient Treatment Regimen - LMWH + Warfarin [128015] Give Warfarin after enoxaparin. ED Treatment Regimen LMWH & Warfarin [157225] Enoxaparin (LOVENOX) Injection 1mg/kg [420334] Warfarin (COUMADIN) Tablet [8748] STAT, Pharmacy To Dose Warfarin [PHA4] Pharmacy Dosing and Education Lovenox/Warfarin [CON100] 1 mg/kg, SubCutaneous, Now (expires in 36 hours), Starting today, For 1 Doses Give warfarin after enoxaparin. STAT 10 mg, Oral, Now (expires in 36 hours), Starting today, For 1 Doses Give warfarin after enoxaparin. STAT Routine,, Pharmacist to notify provider if unable to complete education. ED Provider to Arrange Follow-up with FMG/HHP provider, Routine, Until discontinued, Starting today PCP, or Transition Clinic [NUR195] Physician s Initial: Page 1 of 2 Outpatient DVT Treatment [30400736] PATIENT INFORMATION (3/17/2015)

Discharge Treatment Regimen LMWH & Warfarin [128014] Enoxaparin (LOVENOX) Injection [105900] Ambulatory Referral to Anticoagulation Monitoring [REF111F] Print, 10 Syringe, Refill: 0 Inject ml ( mg total) Under the skin every 12 (twelve) hours for 10 doses. Routine Outpatient Treatment Regimen - Rivaroxaban [157227] ED Treatment Regimen Rivaroxaban [157226] Rivaroxaban (XARELTO) Tablet [110250] Pharmacy Consult: Xarelto Dosing and Education [CON100] ED Provider to Arrange Follow-up with FMG/HHP Provider, PCP, or Transition Clinic [NUR195] 15 mg, Oral, (expires in 36 hours), For 1 Doses With food. STAT STAT,, Pharmacist to notify provider if unable to complete education Routine, Until discontinued, Starting today Discharge Treatment Regimen - Rivaroxaban [128016] Rivaroxaban (XARELTO) 15mg Tablet [112834] Rivaroxaban (XARELTO) 20mg Tablet [112835] Rivaroxaban (XARELTO) 20mg Tablet [112835] Print, 42 tablet, Refill: 0 Take 1 tablet (15 mg total) by mouth 2 (two) times a day. For 21 days. Take with food. Print, 9 tablet, Refill: 0 Take 1 tablet (20 mg total) by mouth daily with dinner. For 9 days. Starting day 22 (after completion of 15 mg twice per day dosing). Normal, 60 tablet, Refill: 0 Take 1 tablet (20 mg total) by mouth daily with dinner. Starting day 31. DATE TIME ORDERING PROVIDER PRINT NAME PROVIDER SIGNATURE DATE TIME RN ACKNOWLEDGED Page 2 of 2 Outpatient DVT Treatment [30400736] PATIENT INFORMATION (3/17/2015)

CHI FRANCISCAN HEALTH SYSTEM ANTICOAGULATION CLINIC REFERRAL FORM FOR ANTICOAGULATION MONITORING St. Joseph Medical Center St. Francis Hospital St. Clare Hospital St. Elizabeth Hospital Gig Harbor 1717 South J Street 34509 Ninth Ave S #308 11311 Bridgeport Way #300 1455 Battersby Ave, #2163A 4700 Pt Fosdick #320 Tacoma Federal Way Lakewood Enumclaw Gig Harbor Highline Wellness Center Harrison Medical Outpatient Center 16233 Sylvester Rd SW S#110 2501 Wheaton Way Burien Bremerton Referral line: 253-573-7470 Fax: 253-573-7187 Please fax signed copy of this patient s referral note back to the Anticoagulation Clinic. Patient will not be scheduled until completed form is received. Patient Information Name: DOB: _ / /_ Sex: Male Female Home Address: Home Phone: _ Work Phone: _ Allergies: Past Medical History/Chronic Conditions: _ Target INR Range: 2.0-3.0 2.5-3.5 Other: Check both boxes (required): Long Term use of Anticoagulants Encounter for therapeutic drug monitoring Indication for Therapy: ICD Code: (required) PE AFIB Mitral Valve Disorder CVA Aortic valve disorder MVR AVR mechanical DVT - specify location: Congestive Heart Failure (CHF) please indicate both the type and acuity: Type: Systolic Diastolic Unspecified Acuity: Acute Chronic Acute On Chronic Unspecified Left Heart Failure Unspecified OTHER: Duration of Therapy (referral must be renewed yearly): 3 months 6 months 12 months OTHER New Start Patient (initializing warfarin therapy) Start therapy per protocol. to start: // Next PT/INR to be drawn: // Patient currently on Warfarin Current Warfarin dose and schedule: Next PT/INR to be drawn: // PT on Fragmin or Lovenox (Please circle appropriate medication) - current dose D/C Fragmin or Lovenox after 1, 2, other in range INR s (American College of Chest Physicians Guidelines recommends 2 in range INR s before D/C of LMWH.) RPH to order additional Lovenox or Fragmin at above dose if INR not in range. If number of in range INR s is not indicated, the FHS Anticoagulation RPh will use CHEST Guidelines recommendations of two in range INR s prior to d/c of LMWH. Physician Information Please be aware: you will need to manage your patients INR until the first visit with the anticoagulation Clinic. You will be notified via fax of patient s first appointment. Phone: Physician Name: FAX: Pager: Physician Signature: : / / Email: By my above signature I the signing and managing physician agree to the Franciscan Health Systems Anticoagulation Clinic Protocol as approved by the Washington State Board of Pharmacy for the individual referred patient named above. I acknowledge that I will renew this individual patient s referral annually. I the signing physician understand I will receive progress notes after each patient visit until patient obtains another care provider or until patient has discontinued anticoagulation medication or is no longer in need of anticoagulation therapy. Updated Physician Signature: : / / Updated Physician Signature: : / / Updated Physician Signature: : / / FHS ANTICOAG REFERRAL LAST REVISED 2/4/2014

Outpatient Anticoagulation Discharge Agreement Letter : Patient Name: Address: City, State, ZIP: Dear Patient: As per our agreement, participation in the Anticoagulation Treatment Program is not in any way to be considered the initiation of a patient/physician relationship. Participation in the program is limited to the treatment and management of your deep vein thrombosis (DVT) and anticoagulation therapy and only until such time that you are considered stable and/or have established a patient/physician relationship with a primary care provider. At this time your condition is considered stable. However, since your condition, DVT, requires additional medical care please contact a new healthcare provider without delay. Please contact one of the organizations below for assistance in finding a new primary care provider. Pierce County Medical Society Referral Services 253-572-3666 King County Medical Society Referral Services 253-621-3963 King County Public Health Center 253-838-4557 Pierce County Public Health Center 253-798-2987 Kitsap County Medical Society 866-844-9355 This is solely your responsibility. Your failure to seek recommended follow up treatment may create complications or crisis that can cause permanent harm or death. Should your medical condition require immediate treatment prior to selecting a new healthcare provider, you are instructed to seek emergency care at the nearest location. Sincerely, ED Medical Provider ED Pharmacist

Dear Patient: Outpatient Anticoagulation Treatment: Enoxaparin (Low Molecular Weight Heparin) & Warfarin Enrollment and Discharge Instructions You have been selected to receive treatment in the outpatient anticoagulation program. Participation in the outpatient treatment program is not in any way to be considered the initiation of a patient/physician relationship. This treatment program is designated to provide transitional care for your deep vein thrombosis (DVT) until such time that you establish a patient/physician relationship with a primary care physician. In an effort to provide the most effective care and to prevent future complications, in order to participate in this program you must agree to the following: You agree to contact the Central Scheduling Office if referred from the St. Joseph Medical Center, St. Francis Hospital, St. Clare Hospital or St. Anthony Hospital at 253-573-7470 to set up your initial intake appointment within 3-5 days of discharge. You agree to contact the Highline Medical Center Anticoagulation Clinic if referred by Highline Medical Center at 206-988-5714 to set up your initial intake appointment within 3-5 days of discharge. You agree to work with the anticoagulation clinic to schedule ongoing appointments, all of which you are expected to keep. You agree to establish a patient/physician relationship with a primary care physician within the next 2 weeks. Your follow-up is in your ED discharge instructions and you have read these thoroughly and understand the instructions. Referral Sources: Pierce County Medical Society Referral Services 253-572-3666 King County Medical Society Referral Services 253-621-3963 King County Public Health Center 253-838-4557 Pierce County Public Health Center 253-798-2987 Kitsap County Medical Society 866-844-9355 You agree to take your medication as prescribed You agree to obtain blood draws as prescribed You agree to report to the nearest emergency room if the following symptoms (bleeding, swelling, chest pain, shortness of breath, or similar symptoms) occur and/or if you have a change in your current health status. If asked to follow up at one of the Franciscan Medical Group (FMG) clinics you agree to schedule and keep the appointment as directed. Your instructions for care are as follows: Receive your first dose of Enoxaparin and Warfarin while in the Emergency Department Receive an educational Enoxaparin teaching kit (VHS/DVD, teaching book, alcohol swabs, sharps container) Receive Warfarin education material Obtain information and paperwork for anticoagulation clinic referral and follow-up Receive two prescriptions: Enoxaparin and Warfarin Fill your prescriptions immediately. For your convenience the Enoxaparin (LMWH), and Warfarin are available at any of the Franciscan Pharmacies at St. Joseph, St. Clare, St. Francis and/or St. Anthony (please see location information below), or you may fill your prescriptions at your local community pharmacy.

Franciscan Pharmacy and Home Medical Supply at St. Joseph Franciscan Pharmacy and Home Medical Supply, St. Anthony 1608 S. J St. Milgard Medical Pavilion Tacoma, WA 98405 11511 Canterwood Blvd. N.W., Suite 220, Gig Harbor Pharmacy: 253-274-7650 Phone: 253-530-2066 Hours: Monday-Friday, 7:30 a.m.-6 p.m. Saturday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy and Compounding, St. Clare Franciscan Pharmacy, Franciscan Medical Pavilion - Bonney Lake 11315 Bridgeport Way S.W., Suite A1087, Lakewood 9230 Sky Island Drive E., Bonney Lake Phone: Pharmacy: 253-985-6290; Supplies: 253-426-6912 Phone: 253-750-6050 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy, Franciscan Medical Pavilion - Canyon Road Franciscan Pharmacy Federal Way - First Avenue 15214 Canyon Road E., Suite 110, Puyallup 30809 First Ave. S., Federal Way Phone: Pharmacy: 253-539-6030 Phone: 253-529-8888 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy and Home Medical Supply, St. Francis 34503 Ninth Ave., Suite 110, Federal Way Phone: Pharmacy: 253-944-4040 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) If you have any questions or concerns, please contact the emergency department. Sincerely, ED Medical Provider ED Pharmacist Initial: I understand the terms of participation in this program and consent to the conditions of the agreement and my responsibilities as outlined above. I understand that participation in this program is limited to treatment and management of my DVT through anticoagulation therapy and only until such time as I am stable and/or I establish a patient/physician relationship with a primary care provider within the time constraints listed above. I understand that participation in this program requires that I actively work to establish a patient/physician relationship with a primary care provider. I understand that participation in this program does not include treatment and/or management of any other health condition I may have. Patient Signature

Dear Patient: Outpatient Anticoagulation Treatment: Rivaroxaban (or alternative Xa inhibitor) Enrollment and Discharge Instructions You have been selected to receive treatment in the outpatient anticoagulation program. Participation in the outpatient treatment program is not in any way to be considered the initiation of a patient/physician relationship. This treatment program is designated to provide transitional care for your deep vein thrombosis (DVT) until such time that you establish a patient/physician relationship with a primary care physician. In an effort to provide the most effective care and to prevent future complications, in order to participate in this program you must agree to the following: You agree to establish a patient/physician relationship with a primary care physician within the next 2 weeks. You agree to work with your primary care physician to schedule ongoing appointments, all of which you are expected to keep. Your follow-up is in your ED discharge instructions and you have read these thoroughly and understand the instructions. Referral Sources: Pierce County Medical Society Referral Services 253-572-3666 King County Medical Society Referral Services 253-621-3963 King County Public Health Center 253-838-4557 Pierce County Public Health Center 253-798-2987 Kitsap County Medical Society 866-844-9355 You agree to take your medication as prescribed You agree to obtain blood draws as prescribed You agree to report to the nearest emergency room if the following symptoms (bleeding, swelling, chest pain, shortness of breath, or similar symptoms) occur and/or if you have a change in your current health status. If asked to follow up at one of the Franciscan Medical Group (FMG) clinics you agree to schedule and keep the appointment as directed. Your instructions for care are as follows: Receive your first dose of Rivaroxaban while in the Emergency Department Receive Rivaroxaban (or alternative Xa inhibitor) education material Receive two prescriptions: Rivaroxaban 15 mg twice daily for 21 days, THEN Rivaroxaban 20 mg daily thereafter for the duration determined by physician (3 months total) (Note: Based on patient specific insurance plans, your treatment medication may change to a similar drug within the same class of medication (Xa inhibitor) if it is considered a preferred agent by your insurance. Such drugs could include but are not limited to Apixaban or Edoxaban) Further dosing beyond 3 months is the responsibility of your primary care provider (if deemed appropriate) Discuss with Pharmacist the available patient medication assistance programs You may receive a follow-up phone call from a Pharmacist within the next month as part of monitoring and evaluation of Rivaroxaban (or alternative Xa inhibitor) therapy. Fill your prescriptions immediately. For your convenience the Rivaroxaban (or alternative Xa inhibitor) are available at any of the Franciscan Pharmacies at St. Joseph, St. Clare, St. Francis and/or St. Anthony (please see location information below), or you may fill your prescriptions at your local community pharmacy.

Franciscan Pharmacy and Home Medical Supply at St. Joseph Franciscan Pharmacy and Home Medical Supply, St. Anthony 1608 S. J St. Milgard Medical Pavilion Tacoma, WA 98405 11511 Canterwood Blvd. N.W., Suite 220, Gig Harbor Pharmacy: 253-274-7650 Phone: 253-530-2066 Hours: Monday-Friday, 7:30 a.m.-6 p.m. Saturday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy and Compounding, St. Clare Franciscan Pharmacy, Franciscan Medical Pavilion - Bonney Lake 11315 Bridgeport Way S.W., Suite A1087, Lakewood 9230 Sky Island Drive E., Bonney Lake Phone: Pharmacy: 253-985-6290; Supplies: 253-426-6912 Phone: 253-750-6050 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy, Franciscan Medical Pavilion - Canyon Road Franciscan Pharmacy Federal Way - First Avenue 15214 Canyon Road E., Suite 110, Puyallup 30809 First Ave. S., Federal Way Phone: Pharmacy: 253-539-6030 Phone: 253-529-8888 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) Franciscan Pharmacy and Home Medical Supply, St. Francis 34503 Ninth Ave., Suite 110, Federal Way Phone: Pharmacy: 253-944-4040 Hours: Monday-Friday, 9 a.m.-5 p.m. (closed 12:30-1 p.m.) If you have any questions or concerns, please contact the emergency department. Sincerely, ED Medical Provider ED Pharmacist Initial: I understand the terms of participation in this program and consent to the conditions of the agreement and my responsibilities as outlined above. I understand that participation in this program is limited to treatment and management of my DVT through anticoagulation therapy and only until such time as I am stable and/or I establish a patient/physician relationship with a primary care provider within the time constraints listed above. I understand that participation in this program requires that I actively work to establish a patient/physician relationship with a primary care provider. I understand that participation in this program does not include treatment and/or management of any other health condition I may have. Patient Signature

Outpatient Anticoagulation Treatment Algorithm: Enoxaparin (LMWH) & Warfarin 1. ED medical provider deems patient acceptable for outpatient treatment. 2. Patient meets inclusion/exclusion criteria. 3. Outpatient DVT Order and Anticoagulation Treatment Packet completed (including discharge prescriptions). 4. ED Medical Provider to complete electronic referral (ref 111f) within EPIC. Option #1 (If appointment can be confirmed prior to discharge from ED): ED pharmacist (if available) may confirm appointment time and date with the Central Scheduling referral line at 253-573-7470 if the discharge is from the St. Joseph Medical Center, St. Francis Hospital, St. Clare Hospital or St. Anthony Hospital during business hours. ED pharmacist (if available) may confirm appointment time and date with the Highline Medical Center Anticoagulation Clinic at 206-988-5714 if the discharge is from the Highline Medical Center during business hours. Option #2 (If appointment can not be confirmed prior to discharge from ED): During nonbusiness hours, a message may be left by the ED pharmacist (if available) to confirm the EPIC referral has been received and the appointment is being arranged. In this case, the patient must also call to the confirm time and date of 3-5 day appointment upon discharge from the ED. 5. ED Medical Provider to arrange follow-up with Franciscan Medical Group, Primary Care Provider or Transition Clinic (if no primary care provider) 6. The Anticoagulation Clinic appointment will be scheduled within 3-5 business days after receipt of the referral. ED pharmacist (if available) to inform patient they should expect a call within 24-72 hours to set up the initial anticoagulation visit. 7. If the patient does not have follow up within the required 3-5 days, they will not be accepted for enrollment in the Anticoagulation clinic and will be required to seek further medical care at the emergency department. 8. ED Pharmacist (if available) to educate patient on LMWH and warfarin therapy utilizing LMWH teaching kit and FHS Warfarin Booklet 9. For EPIC downtime, please use attached Anticoagulation Clinic Referral Form

Outpatient Anticoagulation Treatment Algorithm: Rivaroxaban (or alternative Xa inhibitor) 1. ED Medical provider deems patient acceptable for outpatient treatment. 2. Patient meets inclusion/exclusion criteria. 3. Outpatient DVT Order and Anticoagulation Treatment Packet completed (including discharge prescriptions). 4. ED Pharmacist (if available) to call the outpatient pharmacy to determine if rivaroxaban therapy will be covered by insurance. If an alternative Xa inhibitor is deemed the insurance formulary agent of choice, consult the medical provider to change the outpatient prescriptions to the alternative formulary agent. 5. ED Pharmacist (if available) to complete Patient Assistance Algorithm (agent specific) and assist the patient with the necessary enrollment forms (online or via telephone) to attain authorization for Saving / Co-pay Cards or Free trial vouchers/ offers when necessary if requested by ED Medical provider. 6. ED Pharmacist (if available) to assist in the prior authorization process if requested by ED Medical provider. 7. ED Medical provider to arrange follow-up with Franciscan Medical Group, Primary Care Provider or Transition Clinic (if no primary care provider). 8. ED Pharmacist (if available) to educate patient regarding rivaroxaban (or alternative Xa inhibitor) therapy utilizing the Rivaroxaban Patient Education Guide

Outpatient Anticoagulation Treatment Medication Assistance Algorithm Planned outpatient treatment with anticoagulation Option #1 Enoxaparin (LMWH) & Warfarin Option #2 Rivaroxaban (or alternative Xa Inhibitor) If Rivaroxaban (or alternative Xa inhibitor) access cannot be insured, recommend an alternative DVT treatment modality (Enoxaparin + Warfarin) Call outpatient pharmacy and determine if Rivaroxaban is covered by patient s insurance (if not covered, determine alternative Xa inhibitor formulary agent of choice). Assist patient to attain authorization for Savings / Co-pay Cards or free trial vouchers /offers. Insurance Coverage Unavailable Medicare, Medicare Part D, Medicaid Commercial (Non-Medicare/Medicaid) Insurance Providers Available Programs: Johnson & Johnson Patient Assistance Foundation (http://jjpaf.org/) or Bristol Meyers Squibb Patient Assistance Foundation http://www.bmspaf.org/pages/ho me.aspx Patient must meet financial criteria Determine if patient meets eligibility criteria, complete all required forms, and provide patient with appropriate documentation / copies Available Programs: Xarelto CarePath Program (Online / Phone approval 1-888-927-3586) (#30 days free trial offer) or Eliquis 360 Support Program (Phone approval 1-855-354-7847) (#30 day free trial offer) Note: In most instances, Medicare and Medicaid provide comprehensive drug coverage for their enrolled patients. They typically do not qualify for medication assistance programs beyond the free trial offers Available Programs: Xarelto CarePath Program (Online / Phone approval 1-888- 927-3586) (#30 days free trial offer and no monthly out-ofpocket costs for commercial insurance) or Eliquis 360 Support Program (Phone approval 1-855-354-7847) (#30 day free trial offer and $10 / month out of pocket costs for commercial insurance)